Study Purpose:
The purpose of this study is to explore the genetic causes relevant for ALS development in Norway.Study Status:
Recruiting
Disease:
Amyotrophic Lateral Sclerosis
Study Type:
Observational [Patient Registry]
Type of Intervention:
N/A
Intervention Name:
N/A
Placebo:
N/A
Phase:
N/A
Study Chair(s)/Principal Investigator(s):
Helle Høyer, Telemark Hospital Trust, Norway
Clinicaltrials.gov ID:
Neals Affiliated?
No
Coordinating Center Contact Information
Full Study Summary:
Study Sponsor:
Sykehuset Telemark
Estimated Enrollment:
500
Estimated Study Start Date:
08 / 01 / 2019
Estimated Study Completion Date:
12 / 31 / 2030
Posting Last Modified Date:
07 / 06 / 2022
Date Study Added to neals.org:
11 / 15 / 2021
Minimum Age:
16 Years
Maximum Age:
N/A
Inclusion Criteria:- Probable or definite ALS
- Eligible to consent
Exclusion Criteria:
-
Haukeland University Hospital, Department of Neurology
Bergen
Norway
Møre and Romsdal Hospital Trust, Department of Neurology
Molde
Norway
St. Olavs Hospital, Department of Neurology
Trondheim
Norway
University hospital of North Norway, Department of Neurology
Tromsø
Norway
Stavanger University Hospital, Department of Neurology
Stavanger
Norway
Telemark Hospital, Department of Neurology
Skien
Norway
Oslo University Hospital, Department of Neurology
Oslo
Norway
Nord-Trøndelag Hospital Trust, Department of Neurology
Namsos
Norway
Akershus University Hospital, Department of Neurology
Lørenskog
Norway
Nordland Hospital Trust, Department of Neurology
Bodø
Norway
Innlandet Hospital Trust, Department of Neurology
Lillehammer
Norway
Sørlandet Hospital Trust, Department of Neurology
Kristiansand
Norway
Fonna Hospital Trust, Department of Neurology
Haugesund
Norway
Østfold Hospital Trust, Department of Neurology
Grålum
Norway
Førde Hospital Trust, Department of Neurology
Førde
Norway
Vestre Viken Hospital Trust, Department of Neurology
Drammen
Norway
Vestfold Hospital Trust, Department of Neurology
Tønsberg
Norway